...
首页> 外文期刊>Biomacromolecules >Calcium Stearate as an Effective Alternative to Poly(vinyl alcohol) in Poly-Lactic-co-Glycolic Acid Nanoparticles Synthesis
【24h】

Calcium Stearate as an Effective Alternative to Poly(vinyl alcohol) in Poly-Lactic-co-Glycolic Acid Nanoparticles Synthesis

机译:硬脂酸钙作为聚(乙烯醇)在聚乳酸共乙醇纳米粒子合成中的有效替代物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Poly(D,L-lactic-co-glycolic acid) (PLGA) nano particles (NPs) are among the most studied systems for drug and gene targeting. So far, the synthesis of stable and uniform PLGA NPs has involved the use of a large excess of polyvinyl surfactants such as poly(vinyl alcohol) (PVA) and polyvinylpyrrolidone (PVP), whose removal requires multistep purification procedures of high ecological and economic impact. Hence the development of environment-friendly and cost-effective synthetic procedures for the synthesis of PLGA NPs would effectively boost their use in clinics. This work aims to address this issue by investigating more efficacious alternatives to the so far employed polyvinyl surfactants. More specifically, we developed an innovative synthetic process to achieve stable and uniformly distributed PLGA NPs that involves the use of calcium stearate (CSt), gaining benefits of its high biocompatibility and efficacy at low concentrations and avoiding consequently expensive purification steps. With the help of minimum quantities of polysorbate 60 and sorbitane monostearate, CSt-stabilized PLGA NPs with different sizes and structures were synthesized. The influence of CSt on the encapsulation efficiency of bioactive molecules has been also investigated. The effective encapsulation of both hydrophobic (curcumin) and hydrophilic (fibrinogen labeled with Alexa647) biomolecules into NPs was demonstrated by confocal microscopy, and their release quantified by spectrofluorimetric analyses. Finally, degradation and cytotoxicity studies showed that CSt stabilized NPs were stable under physiological conditions and with good biocompatibility, thus looking promising for further investigation as controlled release devices.
机译:聚(D,L-乳酸 - 共乙醇酸)(PLGA)纳米颗粒(NPS)是最多研究的药物和基因靶向系统。到目前为止,稳定和均匀的PLGA NPS的合成涉及使用大量过量的聚乙烯表面活性剂如聚(乙烯醇)(PVA)和聚乙烯吡咯烷酮(PVP),其去除需要高生态和经济影响的多步净化程序。因此,为合成PLGA NPS的环境友好型和经济高效的合成程序的开发将有效地提高其在诊所的使用。这项工作旨在通过研究到目前为止使用的聚乙烯基表面活性剂的更有效的替代品来解决这个问题。更具体地说,我们开发了一种创新的合成过程,实现稳定且均匀分布的PLGA NP,涉及使用硬脂酸钙(CST),在低浓度下获得其高生物相容性和功效的益处,并避免昂贵的纯化步骤。借助最小量的聚山梨醇酯60和山梨烷单硬脂酸盐,合成了具有不同尺寸和结构的CST稳定的PLGA NP。研究了CST对生物活性分子的封装效率的影响已经研究。通过共聚焦显微镜证明了疏水性(姜黄素)和亲水性(用Alexa647标记的纤维蛋白原)生物分子的有效封装,并通过光谱氟化物分析量化了它们的释放。最后,降解和细胞毒性研究表明,CST稳定的NPS在生理条件下稳定并且具有良好的生物相容性,因此希望进一步调查作为控释装置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号